1.
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
2.
3.
4.
5.
Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019–2021